Find Out if You or a Loved One is Eligible for the BRAVO Clinical Research Trial
Battling hereditary breast cancer can be challenging both physically and emotionally. Participating in a clinical trial can provide a sense of hope. The BRAVO clinical research trial is being conducted to determine whether niraparib, a PARP inhibitor, is effective in patients with breast cancer who are BRCA1 or BRCA2 positive and HER2 negative, and have not responded to other treatments.
When you participate in a clinical research trial, you help to advance research that explores more effective treatments for individuals just like you and families that are affected by hereditary breast cancer.
To learn more about the BRAVO clinical research trial, please contact a research site near you.
Joining together, we can fight against hereditary breast cancer.